Sign In
Buy NYXH
$2.87
-0.100 (-3.37%)
At Close: Jun 03, 2026
Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023
04:30pm, Monday, 01'st May 2023
Nyxoah to Release F irst Quarter 2023 Financial Results on Ma y 16 , 202 3
Strength Seen in Nyxoah SA (NYXH): Can Its 10.2% Jump Turn into More Strength?
08:24am, Friday, 14'th Apr 2023
Nyxoah SA (NYXH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r
Nyxoah S.A. (NYXH) Q4 2022 Earnings Call Transcript
09:26pm, Wednesday, 22'nd Mar 2023
Nyxoah S.A. (NASDAQ:NYXH ) Q4 2022 Earnings Conference Call March 22, 2023 4:30 PM ET Company Participants Olivier Taelman - Chief Executive Officer Loïc Moreau - Chief Financial Officer Conference C
Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023
04:30pm, Wednesday, 08'th Mar 2023Nyxoah S.A. (NYXH) Q3 2022 Results - Earnings Call Transcript
12:38am, Monday, 14'th Nov 2022
Nyxoah S.A. (NASDAQ:NYXH ) Q3 2022 Results Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Jeremy Feffer - Vice President, Investor Relations Olivier Taelman - Chief Executiv
Nyxoah to Release Third Quarter Financial Results on November 8, 2022
04:30pm, Tuesday, 18'th Oct 2022
Nyxoah to Release Third Quarter Financial Results on November 8 , 2022
Nyxoah S.A. (NYXH) CEO Olivier Taelman on Q2 2022 Results - Earnings Call Transcript
05:29pm, Saturday, 13'th Aug 2022
Nyxoah S.A. (NASDAQ:NYXH ) Q2 2022 Results Conference Call August 8, 2022 4:30 PM ET Company Participants Jeremy Feffer - VP, IR Olivier Taelman - CEO Loic Moreau - CFO Conference Call Participants Ro
Nyxoah to Release Second Quarter and First Half 2022 Financial Results on August 8, 2022
04:30pm, Tuesday, 19'th Jul 2022Nyxoah SA (NYXH) Stock Jumps 13.2%: Will It Continue to Soar?
10:00am, Tuesday, 12'th Jul 2022
Nyxoah SA (NYXH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the r
FDA Signs Off Nyxoah's Genio Trial In Complete Concentric Collapse Patients
09:37am, Monday, 11'th Jul 2022
The FDA has approved Nyxoah SA's (NASDAQ: NYXH) Investigational Device Exemption (IDE) to initiate a trial, called ACCCESS, to evaluate the Genio system for moderate-to-severe Obstructive Sleep Apn
Should You Buy Nyxoah (NYXH) Ahead of Earnings?
12:47pm, Tuesday, 22'nd Mar 2022
Nyxoah (NYXH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Nyxoah to Present BETTER SLEEP Data, Host Physician Events at World Sleep Congress 2022
04:30pm, Monday, 07'th Mar 2022
Nyxoah to Present BETTER SLEEP Data, Host Physician Events at World Sleep Congress 2022
Nyxoah to Release Full Year 2021 Financial Results on March 24 and Host Conference Call on March 25, 2022
04:30pm, Thursday, 03'rd Mar 2022
Nyxoah to Release Full Year 2021 Financial Results on March 24 and Host Conference Call on March 25, 2022
Nyxoah to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
04:30pm, Friday, 04'th Feb 2022
Nyxoah to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Nyxoah Announces CE-Mark Indication Approval to Treat Complete Concentric Collapse (CCC) Patients
04:30pm, Monday, 04'th Oct 2021
INSIDE INFORMATION REGULATED INFORMATION
